Molecular Characterization of Gastric Carcinoma: Therapeutic Implications for Biomarkers and Targets

Palliative chemotherapy is the mainstay of treatment of advanced gastric carcinoma (GC). Monoclonal antibodies including trastuzumab, ramucirumab, and pembrolizumab have been shown to provide additional benefits. However, the clinical outcomes are often unpredictable and they can vary widely among p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kankeu Fonkoua, Lionel, Yee, Nelson S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874689/
https://www.ncbi.nlm.nih.gov/pubmed/29522457
http://dx.doi.org/10.3390/biomedicines6010032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874689/
https://www.ncbi.nlm.nih.gov/pubmed/29522457
http://dx.doi.org/10.3390/biomedicines6010032

Ejemplares similares